Risk minimisation materials: Enhertu (trastuzumab deruxtecan) powder for concentrate for solution for infusion

Two separate guides for healthcare professionals advise on the risk of confusion between Enhertu and other trastuzumab-containing products and the risk, diagnosis and management of interstitial lung disease or pneumonitis.

Daiichi Sankyo